680 related articles for article (PubMed ID: 32838725)
1. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO
Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and investigation of the mechanism of action underlying anti-leukemic effects of the quinolinequinones as LY83583 analogs.
Ciftci HI; Bayrak N; Yıldız M; Yıldırım H; Sever B; Tateishi H; Otsuka M; Fujita M; Tuyun AF
Bioorg Chem; 2021 Sep; 114():105160. PubMed ID: 34328861
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
4. A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer.
Orujova T; Ece A; Akalın Çiftçi G; Özdemir A; Altıntop MD
Drug Dev Res; 2023 Apr; 84(2):185-199. PubMed ID: 36469421
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Özdemir A
Molecules; 2018 May; 23(6):. PubMed ID: 29857484
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological activity of Plastoquinone analogs as a new class of anticancer agents.
Bayrak N; Yıldırım H; Yıldız M; Radwan MO; Otsuka M; Fujita M; Tuyun AF; Ciftci HI
Bioorg Chem; 2019 Nov; 92():103255. PubMed ID: 31542717
[TBL] [Abstract][Full Text] [Related]
7. Anticancer properties of N-alkyl-2, 4-diphenylimidazo [1, 2-a] quinoxalin-1-amine derivatives; kinase inhibitors.
Rezaei Z; Mahdi Didehvar M; Mahdavi M; Azizian H; Hamedifar H; Mohammed EHM; Ostad S; Amini M
Bioorg Chem; 2019 Sep; 90():103055. PubMed ID: 31220669
[TBL] [Abstract][Full Text] [Related]
8. Novel guanidine derivatives targeting leukemia as selective Src/Abl dual inhibitors: Design, synthesis and anti-proliferative activity.
Moustafa AH; AboulMagd AM; Ali AM; Khodairy A; Marzouk AA; Nafady A; T M Nemr M
Bioorg Chem; 2024 Jun; 147():107410. PubMed ID: 38688197
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity.
I Ciftci H; O Radwan M; E Ozturk S; Ulusoy NG; Sozer E; E Ellakwa D; Ocak Z; Can M; F S Ali T; I Abd-Alla H; Yayli N; Tateishi H; Otsuka M; Fujita M
Molecules; 2019 Sep; 24(19):. PubMed ID: 31574910
[TBL] [Abstract][Full Text] [Related]
10. A novel series of chlorinated plastoquinone analogs: Design, synthesis, and evaluation of anticancer activity.
Bayrak N; Yıldırım H; Yıldız M; Radwan MO; Otsuka M; Fujita M; Ciftci HI; Tuyun AF
Chem Biol Drug Des; 2020 Mar; 95(3):343-354. PubMed ID: 31785034
[TBL] [Abstract][Full Text] [Related]
11. Discovery and structure-activity relationship of plastoquinone analogs as anticancer agents against chronic myelogenous leukemia cells.
Ciftci HI; Bayrak N; Yıldırım H; Yıldız M; Radwan MO; Otsuka M; Fujita M; Tuyun AF
Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900170. PubMed ID: 31602720
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
[TBL] [Abstract][Full Text] [Related]
13. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
14. Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors.
El-Naggar AM; El-Hashash MA; Elkaeed EB
Bioorg Chem; 2021 Mar; 108():104615. PubMed ID: 33484942
[TBL] [Abstract][Full Text] [Related]
15. The First Pentacyclic Triterpenoid Gypsogenin Derivative Exhibiting Anti-ABL1 Kinase and Anti-chronic Myelogenous Leukemia Activities.
Ciftci HI; Ozturk SE; Ali TFS; Radwan MO; Tateishi H; Koga R; Ocak Z; Can M; Otsuka M; Fujita M
Biol Pharm Bull; 2018 Apr; 41(4):570-574. PubMed ID: 29386476
[TBL] [Abstract][Full Text] [Related]
16. Structure based design, synthesis, and evaluation of anti-CML activity of the quinolinequinones as LY83583 analogs.
Bayrak N; Ciftci HI; Yıldız M; Yıldırım H; Sever B; Tateishi H; Otsuka M; Fujita M; Tuyun AF
Chem Biol Interact; 2021 Aug; 345():109555. PubMed ID: 34146539
[TBL] [Abstract][Full Text] [Related]
17. Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase.
Larocque EA; Naganna N; Opoku-Temeng C; Lambrecht AM; Sintim HO
ChemMedChem; 2018 Jun; 13(12):1172-1180. PubMed ID: 29608815
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives.
Abdel-Maksoud MS; Kim MR; El-Gamal MI; Gamal El-Din MM; Tae J; Choi HS; Lee KT; Yoo KH; Oh CH
Eur J Med Chem; 2015 May; 95():453-63. PubMed ID: 25841200
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
20. Modification of imidazothiazole derivatives gives promising activity in B-Raf kinase enzyme inhibition; synthesis, in vitro studies and molecular docking.
Ammar UM; Abdel-Maksoud MS; Mersal KI; Ali EMH; Yoo KH; Choi HS; Lee JK; Cha SY; Oh CH
Bioorg Med Chem Lett; 2020 Oct; 30(20):127478. PubMed ID: 32781217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
